Organogenesis Holdings Inc. Contracts & Agreements

Stock Repurchase Agreement, dated November 27, 2024, by and between Organogenesis Holdings Inc. and GN 2016 Family Trust u/a/d August 12, 2016 (Filed With SEC on December 2, 2024)

Subscription Agreement, dated November 12, 2024, by and among Organogenesis Holdings Inc., Avista Healthcare Partners III, L.P. and AHP III Orchestra Holdings, L.P (Filed With SEC on November 13, 2024)

Third Amendment to Credit Agreement dated as of November 12, 2024 by and among the Company, the lenders named therein and the administrative agent (Filed With SEC on November 13, 2024)

Form of Stock Repurchase Agreement, dated November 12, 2024 (Filed With SEC on November 13, 2024)

2018 Equity Incentive Plan (as amended) (Filed With SEC on June 21, 2024)

Organogenesis Holdings Inc. 2018 Equity Incentive Plan (as amended) (Filed With SEC on August 9, 2022)

Purchase and Sale Agreement dated as of August 11, 2021 by and between Organogenesis Inc. and 275 Dan Road SPE, LLC (Filed With SEC on August 16, 2021)

Form of Change in Control Retention Agreement (Independent Directors) (Filed With SEC on May 11, 2021)

Change in Control Retention Agreement between Organogenesis Holdings Inc. and Gary S. Gillheeney, Sr. effective as of May 10, 2021 (Filed With SEC on May 11, 2021)

Form of Change in Control Retention Agreement (Non-CEO Executive Officers) (Filed With SEC on May 11, 2021)

Fifth Amendment to Credit Agreement dated and effective as of May 5, 2021 among Organogenesis Holdings Inc., Organogenesis Inc. and Prime Merger Sub, LLC, collectively as... (Filed With SEC on May 10, 2021)

Fourth Amendment to Credit Agreement dated March 31, 2021 among Organogenesis Holdings Inc., Organogenesis Inc. and Prime Merger Sub, LLC, collectively as borrower, and Silicon... (Filed With SEC on April 2, 2021)

Offer Letter dated January 15, 2021 between Organogenesis Holdings Inc. and David C. Francisco (Filed With SEC on February 16, 2021)

Fee Letter Agreement dated November 12, 2020 by and among the Company, the Avista Funds and the Management Company (Filed With SEC on November 18, 2020)

Form of Underwriting Agreement (Filed With SEC on November 10, 2020)

Separation Letter Agreement, dated August 24, 2020, between Organogenesis Holdings Inc. and Timothy M. Cunningham (Filed With SEC on August 24, 2020)

Form of Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on May 11, 2020)

Third Amendment to Credit Agreement dated March 26, 2020 among Organogenesis Holdings Inc., Organogenesis Inc. and Prime Merger Sub, LLC, collectively as borrower, and Silicon... (Filed With SEC on March 30, 2020)

Separation Letter Agreement, dated March 13, 2020, between Organogenesis Holdings Inc. and Howard P. Walthall, Jr (Filed With SEC on March 16, 2020)

Second Amendment to Lease dated February 7, 2020 by and between Oxmoor Holdings, LLC and Organogenesis Inc (Filed With SEC on March 9, 2020)

Fourth Amendment to Lease dated February 14, 2020 by and between Liberty Industrial Park and Organogenesis Inc (Filed With SEC on March 9, 2020)

Description of Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 9, 2020)

Second Amendment to Credit Agreement entered into on February 14, 2020 and dated and effective as of February 13, 2020 among Organogenesis Holdings Inc., Organogenesis Inc. and... (Filed With SEC on February 19, 2020)

Fee Letter Agreement dated November 19, 2019 by and among the Company, the Avista Funds and the Management Company (Filed With SEC on November 22, 2019)

Underwriting Agreement, dated November 21, 2019, by and among Credit Suisse Securities (USA) LLC and SVB Leerink LLC, as representatives of the underwriters named in Schedule A... (Filed With SEC on November 22, 2019)

First Amendment to Credit Agreement dated November 12, 2019 among Organogenesis Holdings Inc., Organogenesis Inc. and Prime Merger Sub, LLC, collectively as borrower, and Silicon... (Filed With SEC on November 15, 2019)

Amendment No. 1 to Warrant Agreement, dated as of August 19, 2019, by and between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on August 19, 2019)

Amended and Restated Subordination Agreement dated as of August 6, 2019 by and among Dan Road Associates LLC, 85 Dan Road Associates LLC, 275 Dan Road SPE LLC, 65 Dan Road SPE LLC... (Filed With SEC on August 8, 2019)

Letter Agreement dated as of August 6, 2019 by and among Organogenesis Inc., Dan Road Associates LLC, 85 Dan Road Associates LLC, 275 Dan Road SPE LLC and 65 Dan Road SPE LLC (Filed With SEC on August 8, 2019)

Warrant Exchange Agreement dated as of July 12, 2019 by and among Organogenesis Holdings Inc., Avista Capital Partners IV L.P., Avista Capital Partners IV (Offshore), L.P (Filed With SEC on July 16, 2019)

Lease dated March 13, 2019 between Organogenesis Inc., as tenant, and Bobson Norwood Commercial, LLC, as landlord (Filed With SEC on March 19, 2019)

Exchange Agreement, dated August 17, 2018, by and among Avista Healthcare Public Acquisition Corp. and certain lenders listed on Schedule A therein (Filed With SEC on March 18, 2019)

Eighth Amendment to Credit Agreement and Amendment to Consent Agreement dated as of December 31, 2018 by and among Organogenesis Inc., Prime Merger Sub, LLC and Silicon Valley Bank (Filed With SEC on January 7, 2019)

Employee Letter Agreement dated as of February 14, 2017 by and between Organogenesis Inc. and Patrick Bilbo (Filed With SEC on December 11, 2018)

Replacement Common Stock Purchase Warrant issued to Massachusetts Capital Resource Company on November 3, 2010 (Filed With SEC on December 11, 2018)

Agreement and Plan of Merger dated as of March 18, 2017 by and among Organogenesis Inc., Prime Merger Sub, LLC, Nutech Medical, Inc., Howard P. Walthall, Jr., Gregory J. Yager,... (Filed With SEC on December 11, 2018)

Replacement Common Stock Purchase Warrant issued to Life Insurance Community Investment Initiative, LLC on November 3, 2010 (Filed With SEC on December 11, 2018)

Secured Promissory Note dated July 3, 2012 issued by Geoff MacKay and payable to Organogenesis Inc (Filed With SEC on December 11, 2018)

Secured Promissory Note dated July 1, 2011 issued by Geoff MacKay and payable to Organogenesis Inc (Filed With SEC on December 11, 2018)

Secured Promissory Note dated November 17, 2010 issued by Geoff MacKay and payable to Organogenesis Inc (Filed With SEC on December 11, 2018)

Separation Agreement dated as of March 4, 2015 by and between Organogenesis Inc. and Geoff MacKay (Filed With SEC on December 11, 2018)

Employee Letter Agreement dated as of May 9, 2017 by and between Organogenesis Inc. and Brian Grow (Filed With SEC on December 11, 2018)

Employee Letter Agreement dated as of January 19, 2018 by and between Organogenesis Inc. and Lori Freedman (Filed With SEC on December 11, 2018)

Employee Agreement dated as of March 18, 2017 by and between Organogenesis Inc. and Howard P. Walthall, Jr., as amended by that certain First Amendment dated as of October 10, 2017 (Filed With SEC on December 11, 2018)

Employee Letter Agreement dated as of February 14, 2017 by and between Organogenesis Inc. and Antonio Montecalvo (Filed With SEC on December 11, 2018)

Employee Letter Agreement dated as of July 15, 2016 by and between Organogenesis Inc. and Timothy Cunningham (Filed With SEC on December 11, 2018)

Amended and Restated Key Employee Agreement dated as of February 1, 2007 by and between Organogenesis Inc. and Gary Gillheeney (Filed With SEC on December 11, 2018)

Standard Industrial/Commercial Multi-Tenant LeaseNet, dated as of March 7, 2011, by and among Liberty Industrial Park and Organogenesis Inc., as amended by that certain First... (Filed With SEC on December 11, 2018)

Lease Agreement, dated as of January 1, 2014, by and between Oxmoor Holdings, LLC and Prime Merger Sub, LLC (as successor-in-interest to Nutech Medical, Inc.) (Filed With SEC on December 11, 2018)

Lease Agreement, dated as of June 5, 2012, by and between Organogenesis Switzerland GmbH and Stiftung Regionales Grnderzentrum Reinach, as amended by that certain Supplement No. 1... (Filed With SEC on December 11, 2018)

Sublease Agreement dated as of March 18, 2014 by and between Organogenesis Inc. and Shire Holdings US AG, as amended by that certain First Amendment to Sublease dated as of... (Filed With SEC on December 11, 2018)

Lease Agreement dated as of March 6, 2017 by and between Organogenesis Inc. and ARE-10933 North Torrey Pines, LLC (Filed With SEC on December 11, 2018)

Lease dated as of January 1, 2013 by and between Organogenesis Inc. and 275 Dan Road SPE, LLC (Filed With SEC on December 11, 2018)

Lease dated as of January 1, 2013 by and between Organogenesis Inc. and Dan Road Equity I, LLC (Filed With SEC on December 11, 2018)

Lease dated as of January 1, 2013 by and between Organogenesis Inc. and 85 Dan Road Associates, LLC (Filed With SEC on December 11, 2018)

Lease dated as of January 1, 2013 by and between Organogenesis Inc. and 65 Dan Road SPE, LLC (Filed With SEC on December 11, 2018)

License and Services Agreement, dated as of September 14, 2011, by and between Organogenesis Inc. and Net Health Systems, Inc., as amended by that certain First Amendment dated as... (Filed With SEC on December 11, 2018)

Stockholders Agreement dated as of December 10, 2018 among ORGO, Avista Capital Partners Fund IV L.P., Avista Capital Partners Fund IV (Offshore), L.P., and certain holders of... (Filed With SEC on December 11, 2018)

Amended and Restated Registration Rights Agreement dated as of December 10, 2018 among ORGO, Avista Acquisition Corp., Avista Capital Partners Fund IV L.P., Avista Capital... (Filed With SEC on December 11, 2018)

Amended Letter Agreement, dated October 30, 2018, by and among Avista Healthcare Public Acquisition Corp., its officers and directors and Avista Acquisition Corp (Filed With SEC on October 30, 2018)

Amendment No. 1 to Merger Agreement, dated October 5, 2018, by and among Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis, Inc (Filed With SEC on October 9, 2018)

Amendment No. 1, dated as of October 4, 2018, to the Investment Management Trust Agreement, dated as of October 10, 2016, between the Company and Continental Stock Transfer &... (Filed With SEC on October 4, 2018)

Form of Warrant Agreement to be entered into by Avista Healthcare Public Acquisition Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on August 29, 2018)

Mutual Termination Agreement, dated February 14, 2018, by and among Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc., Avista Healthcare NewCo, LLC... (Filed With SEC on March 14, 2018)

Amendment No. 3 to Transaction Agreement, dated January 21, 2018, by and among Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc., Avista Healthcare... (Filed With SEC on January 22, 2018)

Amended and Restated Letter Agreement, dated January 21, 2018, by and among Avista Healthcare Public Acquisition Corp., Avista Acquisition Corp., Hkan Bjrklund, Charles Harwood,... (Filed With SEC on January 22, 2018)

Amendment No. 2 to Transaction Agreement, dated December 22, 2017, by and among Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc., Avista Healthcare... (Filed With SEC on December 26, 2017)

Amendment No. 1 to Transaction Agreement, dated November 22, 2017, by and among Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc., Avista Healthcare... (Filed With SEC on November 22, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 14, 2016)

WARRANT AGREEMENT AVISTA HEALTHCARE PUBLIC ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated as of October 10, 2016 (Filed With SEC on October 14, 2016)

INVESTMENT MANAGEMENT TRUST AGREEMENT (Filed With SEC on October 14, 2016)

PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (Filed With SEC on October 14, 2016)

Avista Healthcare Public Acquisition Corp. 65 East 55th Street 18th Floor New York, NY 10022 (Filed With SEC on October 14, 2016)

30,000,000 Units Avista Healthcare Public Acquisition Corp. UNDERWRITING AGREEMENT (Filed With SEC on September 30, 2016)

FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT (Filed With SEC on September 30, 2016)

FORM OF REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 30, 2016)

FORM OF PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (Filed With SEC on September 30, 2016)

FORM OF INDEMNITY AGREEMENT (Filed With SEC on September 2, 2016)

Avista Healthcare Public Acquisition Corp. 65 East 55th Street 18th Floor New York, NY 10022 (Filed With SEC on September 2, 2016)

AVISTA HEALTHCARE PUBLIC ACQUISITION CORP. UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE WARRANT TO PURCHASE ONE-HALF OF ONE CLASS A ORDINARY SHARE THIS CERTIFIES THAT is... (Filed With SEC on September 2, 2016)

Avista Healthcare Public Acquisition Corp. c/o Avista Capital Holdings, LP 65 East 55th Street 18th Floor New York, NY 10022 December 14, 2015 (Filed With SEC on September 2, 2016)

FORM OF REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 2, 2016)

FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT (Filed With SEC on September 2, 2016)

AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on September 2, 2016)

FORM OF WARRANT AGREEMENT AVISTA HEALTHCARE PUBLIC ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated as of , 2016 (Filed With SEC on September 2, 2016)

[FACE] (Filed With SEC on September 2, 2016)

AVISTA HEALTHCARE PUBLIC ACQUISITION CORP. INCORPORATED UNDER THE LAWS OF THE CAYMAN ISLANDS CLASS A ORDINARY SHARES (Filed With SEC on September 2, 2016)

Category

Industry

Companies

Contracts

Organogenesis Holdings Inc. Contracts & Agreements